Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm

被引:14
|
作者
Huang, Chien-Sheng [1 ,2 ]
Hsu, Po-Kuei [1 ]
Chen, Chun-Ku [3 ]
Yeh, Yi-Chen [4 ]
Hsu, Han-Shui [1 ]
Shih, Chun-Che [2 ,5 ]
Huang, Biing-Shiun [1 ]
机构
[1] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan
[2] Sch Med, Inst Clin Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan
关键词
Early stage lung cancer; non-small cell lung cancer; segmentectomy; sublobar resection; wedge resection; CELL LUNG-CANCER; SECTION COMPUTED-TOMOGRAPHY; LIMITED RESECTION; WEDGE RESECTION; HIGH-RISK; TNM CLASSIFICATION; TUMOR SIZE; LOBECTOMY; SEGMENTECTOMY; SURVIVAL;
D O I
10.1111/1759-7714.13336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background This study aimed to compare survival between standard lobectomy and surgeons' preference sublobar resection among patients with stage I non-small cell lung cancer (NSCLC). Methods Medical records of patients undergoing pulmonary resection between 2006 and 2016 were reviewed retrospectively. Differences in disease-free survival (DFS) and DFS-associated factors between patients receiving lobectomy and surgeons' preference sublobar resection were analyzed after 1-1 propensity score-matching (n = 119 per group). Results In total, 1064 pathological stage I NSCLC patients were identified, including 816 (76.7%) who underwent lobectomy, 111 (10.4%) who underwent sublobar resection as a compromised procedure (medically unfit), and 137 (12.9%) who underwent surgeons' preference sublobar resection. Rates of five-year DFS for patients undergoing lobectomy, medically unfit, and surgeons' preference sublobar resection were 88.7%, 71.0%, and 93.4%, respectively (P < 0.001). Multivariable Cox regression analysis demonstrated that radiological solid-appearance (adjusted hazard [aHR] = 2.908, P = 0.003), PL2 invasion (aHR = 1.970, P = 0.024), and angiolymphatic invasion (aHR = 2.202, P = 0.005) were significantly associated with lower DFS after adjusting for surgeons' preference sublobar resection (aH = 1.031, P = 0.939). Subgroup analysis of all 403 solid-dominant patients demonstrated equivalent five-year DFS between surgeons' preference sublobar resection and lobectomy (87.7% and 84.1%, respectively, P = 0.721). Propensity-matched analysis showed no differences in five-year DFS in stage I NSCLC patients undergoing lobectomy or surgeons' preference sublobar resection (90.5% vs. 93.4% P = 0.510), and DFS for surgeons' preference sublobar resection remained an insignificant factor (aHR = 0.894, P = 0.834). Conclusions Carefully selected patients who have undergone surgeons' preference sublobar resection have comparable outcomes to those receiving lobectomy for stage I NSCLC Significant findings of the study Intended sublobar resection has a good outcome. What this study adds Sublobar resection is applicable for stage I NSCLC <3 cm.
引用
收藏
页码:907 / 917
页数:11
相关论文
共 50 条
  • [1] Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm (vol 11, pg 907, 2020)
    Huang, C. S.
    Hsu, P. K.
    Chen, C. K.
    Yeh, Y. C.
    Hsu, H. S.
    Shih, C. C.
    Huang, B. S.
    THORACIC CANCER, 2021, 12 (19) : 2630 - 2630
  • [2] SBRT Versus Sublobar Resection for Stage I NSCLC
    Ackerson, B.
    Hong, J. C.
    Kelsey, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E436 - E436
  • [3] Patterns of Failure with SBRT Versus Sublobar Resection for Stage I NSCLC
    Ackerson, B.
    Hong, J. C.
    Kelsey, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E668 - E668
  • [4] Role of Adjuvant Chemotherapy After Sublobar Resection in Stage I NSCLC
    Pathak, R.
    Goldberg, S.
    Hoag, J.
    Monsalve, A.
    Resio, B.
    Papageorge, M.
    Boffa, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S886 - S886
  • [5] Is Sublobar Resection for Stage I Invasive Adenocarcinoma (≤2-cm) Feasible?
    Terada, Y.
    Takahashi, T.
    Nitadori, J.
    Kitano, K.
    Nagayama, K.
    Anraku, M.
    Sato, M.
    Shinozaki-Ushiku, A.
    Morita, S.
    Nakajima, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1018 - S1018
  • [6] Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
    Ackerson, Bradley G.
    Tong, Betty C.
    Hong, Julian C.
    Gu, Lin
    Chino, Junzo
    Trotter, Jacob W.
    D'Amico, Thomas A.
    Torok, Jordan A.
    Lafata, Kyle
    Chang, Catherine
    Kelsey, Chris R.
    LUNG CANCER, 2018, 125 : 185 - 191
  • [7] LOBECTOMY IS SUPERIOR TO SUBLOBAR RESECTION OF NON-SMALL CELL LUNG CANCERS LESS THAN 2 CM.
    Sharma, Rohit
    Demmy, Michael
    Groman, Adrienne
    Hennon, Mark
    Dexter, Elisabeth U.
    Nwogu, Chukwumere
    Demmy, Todd L.
    Miller, Austin
    Yendamuri, Sai
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S436 - S436
  • [8] Sublobar resection is non-inferior to lobectomy in very early stage NSCLC
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (04) : 209 - 209
  • [9] Sublobar resection is non-inferior to lobectomy in very early stage NSCLC
    Diana Romero
    Nature Reviews Clinical Oncology, 2023, 20 : 209 - 209
  • [10] Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm
    Lei, Xi
    Zhou, Ning
    Zhang, Hao
    Li, Tong
    Ren, Fan
    Zhang, Bo
    Li, Xiongfei
    Zu, Lingling
    Song, Zuoqing
    Xu, Song
    CANCERS, 2022, 14 (13)